Skip to main content
Top
Published in: The Journal of Obstetrics and Gynecology of India 1/2017

01-02-2017 | Original Article

Over-the-counter MTP Pills and Its Impact on Women’s Health

Authors: Sarojini, T. R. Ashakiran, B. T. Bhanu, Radhika

Published in: The Journal of Obstetrics and Gynecology of India | Issue 1/2017

Login to get access

Abstract

Objectives

To study the complications and consequences including maternal morbidity and mortality following indiscriminate self-consumption of abortion pills reporting to a tertiary care center.

Methodology

This is an observational study conducted at Vanivilas hospital between January 2012 to December 2013 for 24 months. After applying inclusion and exclusion criteria, 104 women were studied with respect to period of gestation, parity, clinical features at presentation and management in the institution. An analysis of maternal morbidity and mortality was done with respect to surgical interventions, ICU admissions, need for blood transfusions and maternal deaths.

Observations and results

In this study, there were 75 (72.2 %) cases of incomplete abortion, 10 (9.6 %) cases of missed abortion, 2 (1.9 %) cases of ruptured ectopic and 2 (1.9 %) cases of rupture uterus. Seventy-eight (75 %) cases received blood transfusion, 7 (6.7 %) were admitted to ICU, and 2 (1.9 %) developed acute kidney injury. There were 2 (1.9 %) maternal deaths in the study group.

Conclusion

This study shows urgent need for legislation and restriction of drugs used for medical termination of pregnancy. Drugs should be made available via health care facilities under supervision to reduce maternal mortality and morbidity due to indiscriminate use of these pills.
Literature
1.
go back to reference Cunningham FG, Leveno KJ, Bloom SL, Haulh JC, Gilstrap LC, Wenstrom KD, editors. Abortion. Williams Textbook of Obstetrics, 24th ed. New York: McGraw-Hill; 2014. pp. 215–235. Cunningham FG, Leveno KJ, Bloom SL, Haulh JC, Gilstrap LC, Wenstrom KD, editors. Abortion. Williams Textbook of Obstetrics, 24th ed. New York: McGraw-Hill; 2014. pp. 215–235.
2.
go back to reference Chaudhari SK. Pregnancy termination. In: Practice of Fertility Control a Comprehensive Manual, 7th ed. New Delhi: Elsevier; pp 237–263. Chaudhari SK. Pregnancy termination. In: Practice of Fertility Control a Comprehensive Manual, 7th ed. New Delhi: Elsevier; pp 237–263.
3.
go back to reference International Consensus Conference on Non-surgical (Medical) Abortion in Early First Trimester on Issues Related to Regimens and Service Delivery. Frequently asked clinical questions about medical abortion. Geneva: World Health Organization; 2006. ISBN 92-4-159484-5. International Consensus Conference on Non-surgical (Medical) Abortion in Early First Trimester on Issues Related to Regimens and Service Delivery. Frequently asked clinical questions about medical abortion. Geneva: World Health Organization; 2006. ISBN 92-4-159484-5.
4.
go back to reference Ellertson C, Waldman SN. The Mifepristone–Misoprostol regimen for early medical abortion. Curr Women Health Rep. 2001;1:184–90. Ellertson C, Waldman SN. The Mifepristone–Misoprostol regimen for early medical abortion. Curr Women Health Rep. 2001;1:184–90.
5.
go back to reference Thaker RV, Deliwala KJ, Shah PT. Self medication of abortion pill: women’s Health in Jeopardy. NHL J Med Sci. 2014; 3(1):26–31. Thaker RV, Deliwala KJ, Shah PT. Self medication of abortion pill: women’s Health in Jeopardy. NHL J Med Sci. 2014; 3(1):26–31.
7.
go back to reference Kapur K, Joneja GS, Biswas M. Medical abortion—an alternative to surgical abortion. MJAFI. 2006;62:351–3. Kapur K, Joneja GS, Biswas M. Medical abortion—an alternative to surgical abortion. MJAFI. 2006;62:351–3.
8.
go back to reference Coyaji K. Early medical abortion in India: three studies and their implications for abortion services. J Am Med Womens Assoc. 2000;55(3 suppl):191–4. Coyaji K. Early medical abortion in India: three studies and their implications for abortion services. J Am Med Womens Assoc. 2000;55(3 suppl):191–4.
10.
go back to reference Bajwa SK, Bajwa SJS, Ghai GK, Singh N, Singh A, Goraya SPS. Medical abortion: is it a blessing or curse for the developing nations? Sri Lanka J Obstet Gynaecol. 2011;33(3):84–90. Bajwa SK, Bajwa SJS, Ghai GK, Singh N, Singh A, Goraya SPS. Medical abortion: is it a blessing or curse for the developing nations? Sri Lanka J Obstet Gynaecol. 2011;33(3):84–90.
11.
go back to reference Tran NT, Jang MC, Choe YS, et al. Feasibility, efficacy, safety and acceptability of Mifepristone–Misoprostol for medical abortion in the Democratic People’s Republic of Korea. Int J Gynecol Obstet. 2010;109(3):209–12.CrossRef Tran NT, Jang MC, Choe YS, et al. Feasibility, efficacy, safety and acceptability of Mifepristone–Misoprostol for medical abortion in the Democratic People’s Republic of Korea. Int J Gynecol Obstet. 2010;109(3):209–12.CrossRef
12.
go back to reference Debnath J, Gulati S, Mathur A, et al. Ectopic pregnancy in the era of medical abortion: are we ready for it? Spectrum of sonographic findings and our experience in a tertiary care service hospital of India. J Obstet Gynecol India. 2013;66(6):388–93.CrossRef Debnath J, Gulati S, Mathur A, et al. Ectopic pregnancy in the era of medical abortion: are we ready for it? Spectrum of sonographic findings and our experience in a tertiary care service hospital of India. J Obstet Gynecol India. 2013;66(6):388–93.CrossRef
13.
go back to reference Hausknecht R. Mifepristone and Misoprostol for early medical abortion: 18 months experience in United States. Contraception. 2003;67:463–5.CrossRefPubMed Hausknecht R. Mifepristone and Misoprostol for early medical abortion: 18 months experience in United States. Contraception. 2003;67:463–5.CrossRefPubMed
14.
go back to reference Deshpande S, Yelikar K, Deshmukh A, et al. Comparative study of medical abortion by Mifepristone with vaginal Misoprostol in women <49 days versus 50–63 days of amenorrhoea. J Obstet Gynecol India. 2010;60(5):403–7.CrossRef Deshpande S, Yelikar K, Deshmukh A, et al. Comparative study of medical abortion by Mifepristone with vaginal Misoprostol in women <49 days versus 50–63 days of amenorrhoea. J Obstet Gynecol India. 2010;60(5):403–7.CrossRef
Metadata
Title
Over-the-counter MTP Pills and Its Impact on Women’s Health
Authors
Sarojini
T. R. Ashakiran
B. T. Bhanu
Radhika
Publication date
01-02-2017
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue 1/2017
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-016-0916-9

Other articles of this Issue 1/2017

The Journal of Obstetrics and Gynecology of India 1/2017 Go to the issue